Enantioselective Synthesis of PPAR (Peroxisome Proliferator-Activated Receptors) Agonists and Antagonists

被引：1

作者：

Goya, Pilar ^{[1
]}

Perez-Fernandez, Ruth ^{[1
]}

Gonzalez-Muniz, Rosario ^{[1
]}

Elguero, Jose ^{[1
]}

机构：

[1] CSIC, Inst Quim Med, E-28006 Madrid, Spain

来源：

CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2014年 / 14卷 / 10期

关键词：

PPAR; enantioselective separation; enantioselective synthesis; Evans' chiral auxiliary; asymmetric hydrogenation; chiral HPLC; chiral salts; PHENYLPROPANOIC ACID-DERIVATIVES; EFFICIENT ASYMMETRIC-SYNTHESIS; ALPHA/GAMMA DUAL AGONISTS; LIGAND-BINDING DOMAIN; BIOLOGICAL EVALUATION; ALPHA AGONIST; DESIGN; POTENCY; AGENTS;

D O I：

10.2174/1568026614666140423112822

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

This review deals with stereoselective issues in PPAR ligands some of which are in clinical use for treating certain metabolic disorders. After a short introduction of these nuclear receptor and their agonists, some cases of enantioselective separations are reported. The main part concerns stereoselective synthesis first starting with asymmetric synthesis from chiral precursors followed by what we refer to as "true" enantioselective methods. Some examples are discussed in detail for each particular heading.

引用

页码：1283 / 1293

页数：11

共 50 条

[41] Peroxisome proliferator-activated receptors for hypertension
Usuda, Daisuke
Kanda, Tsugiyasu
WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (08): : 744 - 754
[42] Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) δ-selective agonists
Kasuga, Jun-ichi
Nakagome, Izumi
Aoyama, Atsushi
Sako, Kumiko
Ishizawa, Michiyasu
Ogura, Michitaka
Makishima, Makoto
Hirono, Shuichi
Hashimoto, Yuichi
Miyachi, Hiroyuki
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (15) : 5177 - 5190
[43] Peroxisome proliferator-activated receptors.
Ziouzenkova O.
Perrey S.
Marx N.
Bacqueville D.
Plutzky J.
Current Atherosclerosis Reports, 2002, 4 (1) : 59 - 64
[44] Peroxisome Proliferator-Activated Receptors and Atherosclerosis
Soskic, Sanja S.
Dobutovic, Branislava D.
Sudar, Emina M.
Obradovic, Milan M.
Nikolic, Dragana M.
Zaric, Bozidarka L.
Stojanovic, Srdan D.
Stokic, Edita J.
Mikhailidis, Dimitri P.
Isenovic, Esma R.
ANGIOLOGY, 2011, 62 (07) : 523 - 534
[45] Signalling by peroxisome proliferator-activated receptors
Wahli, W
Krey, G
Devchand, P
Keller, H
Ijpenberg, A
Jeannin, E
Braissant, O
Desvergne, A
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 : U79 - U79
[46] Peroxisome proliferator-activated receptors and angiogenesis
Biscetti, F.
Straface, G.
Pitocco, D.
Zaccardi, F.
Ghirlanda, G.
Flex, A.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (11) : 751 - 759
[47] Regulation of peroxisome proliferator-activated receptors
Sorensen, HN
Treuter, E
Gustafsson, JA
VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 54, 1998, 54 : 121 - 166
[48] Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ) -: Synthesis and biological activity
Sznaidman, ML
Haffner, CD
Maloney, PR
Fivush, A
Chao, E
Goreham, D
Sierra, ML
LeGrumelec, C
Xu, HE
Montana, VG
Lambert, MH
Willson, TM
Oliver, WR
Sternbach, DD
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (09) : 1517 - 1521
[49] Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPARα and PPARδ
Smeets, Pascal J. H.
Teunissen, Birgit E. J.
Planavila, Anna
de Vogel-van den Bosch, Heleen
Willemsen, Peter H. M.
van der Vusse, Ger J.
van Bilsen, Marc
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (43) : 29109 - 29118
[50] Evolution of peroxisome proliferator-activated receptor agonists
Chang, Feng
Jaber, Linda A.
Berlie, Helen D.
O'Connell, Mary Beth
ANNALS OF PHARMACOTHERAPY, 2007, 41 (06) : 973 - 983

← 1 2 3 4 5 →